Alercell Launches Website Dedicated to New Cancer Detection Tests
Alercell has launched a new website—Lena Diagnostics—dedicated to proprietary tests focused on early detection of cancer and leukemia.
Alercell has launched a new website—Lena Diagnostics—dedicated to proprietary tests focused on early detection of cancer and leukemia.
Werfen is set to acquire Immucor, a privately held corporation with a strong presence in transfusion and transplant in vitro diagnostics.
Quest Diagnostics and Summa Health have announced a definitive agreement for Quest to acquire select assets of Summa Health's LabCare Plus.
Karkinos Healthcare has begun using OptraSCAN’s high-performance digital pathology platform to enhance care for their patient population.
Read MoreQuest Diagnostics launched an obstetrics lab test panel that enables physicians to screen pregnant people easily & reliably for hepatitis C.
Read MoreTotal Testing Solutions announced a partnership with OmniPathology to offer oral HPV testing in the Los Angeles area.
Read MoreNanopath will develop & commercialize a biosensing platform that aims to transform how women’s pelvic & gynecologic infections are diagnosed.
Read MoreBD will offer Accelerate Diagnostic’s rapid testing solution for antibiotic resistance and susceptibility, which provides results in hours.
Read MoreENHERTU is a specifically engineered HER2 directed antibody drug conjugate developed and commercialized by Daiichi Sankyo and AstraZeneca.
Read MoreThomas Scientific has acquired Minneapolis-based laboratory equipment and cleanroom supply provider North Central Instruments (NCI).
Read MoreQuest Diagnostics is launching a multi-faceted initiative to provide better healthcare among America’s large and growing Hispanic community.
Read MoreGenomenon announced a partnership with Rady Children’s Institute for Genomic Medicine to improve diagnosis & treatment decisions for newborns.
Read MoreBrightInsight launched its digital Connected Diagnostics Platform at the 2022 AACC Annual Scientific Meeting and Clinical Lab Expo.
Read MoreNatera, a global provider in cfDNA testing, has been selected to participate in UnitedHealthcare’s Preferred Laboratory Network.
Read MoreMilliporeSigma broke ground at its Sheboygan, Wisconsin site, for the company’s first lateral flow membrane production facility in the U.S.
Read MoreNorthwest Pathology announced that with its earlier acquisition of Avero Diagnostics in 2021, the company adopted the Avero Diagnostics name.
Read MoreGestalt Diagnostics announced a new AI solution that is aimed at improving the speed and accuracy of time-consuming, manual data entry tasks.
Read MoreMeridian Bioscience, a provider of diagnostic testing solutions and life science raw materials, entered into a definitive merger agreement.
Read More